Vesalius Therapeutics CEO and Flagship CEO-Partner Christopher Austin describes how Vesalius has developed the first precision platform for common diseases and what’s ahead for the company as its lead candidates approach the clinic. More from Flagship @ JPM2024 here.
Related Companies
- Vesalius Therapeutics Founded: 2019
